Ruzanna Papyan: First Multicountry Prospective POEM Trial Accepted for Presentation at SIOP 2026
Ruzanna Papyan/LinkedIn

Ruzanna Papyan: First Multicountry Prospective POEM Trial Accepted for Presentation at SIOP 2026

Ruzanna Papyan, Chief of Pediatric Oncology Department at PCBDC of Armenia, Clinical Research Physician at Immune Oncology Research Institute, shared a post on LinkedIn:

“I am very pleased to share, that our abstract, “Implementing the First Multicountry Prospective Clinical Trial within the POEM Group,” has been accepted as a Poster on Board Presentation at the 58th Congress of the International Society of Paediatric OncologySIOP2026, which will take place in San Antonio, Texas.
Our work focuses on the real-world implementation of the first multicountry prospective clinical trial within the POEM Group. Here we describe the practical steps of trial implementation.

I am grateful to all participating centers, colleagues, coordinators, and collaborators who have contributed to this effort.

This project is truly a collective achievement, and I am proud that we will have the opportunity to present it at SIOP 2026.”

Ruzanna Papyan

Other articles featuring Ruzanna Papyan on OncoDaily.